Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:526-527
Published online before print January 15, 2004, doi: 10.1161/01.STR.0000109770.47776.2D
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/2/526    most recent
01.STR.0000109770.47776.2Dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boysen, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boysen, G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke

(Stroke. 2004;35:526.)
© 2004 American Heart Association, Inc.


Original Contributions

Editorial Comment—Persisting Dilemma: To Treat or Not to Treat Blood Pressure in Acute Ischemic Stroke

Gudrun Boysen, MD, DMSc, Guest Editor

Department of Neurology, Bispebjerg Hospital, Copenhagen, Denmark


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Treatment of blood pressure in acute stroke is controversial, whether attempts are made to reduce or to increase blood pressure. Few clinical studies are available to guide clinicians. A Cochrane review1 on deliberately altering blood pressure within 2 weeks of stroke onset found 5 small trials, involving 218 patients randomized to nimodipine, nicardipine, captopril, clonidine, glyceryl trinitrate, or perindopril versus placebo or control treatment. The limited number of data made it impossible to assess the relationship between blood pressure and clinical outcome.

Ahmed et al2 made a post hoc analysis on the effect of intravenous nimodipine in acute ischemic stroke within 24 hours. They found that a reduction of diastolic blood pressure of about 15 mm Hg was associated with poor outcome, whereas a spontaneous fall in the placebo group of about 8 mm Hg was associated with a better outcome.

In this issue of Stroke, Castillo et al found that a fall in systolic blood pressure of more than 20 mm Hg was associated with neurological deterioration and poor outcome. This was an observational study in 258 acute stroke patients, of whom many had their blood pressure lowered. Antihypertensive treatment was started already in the emergency department by other doctors than those involved in the study. The blood pressure–lowering treatment was given according to international guidelines, which, however, are based on reasoning rather than on evidence. Antihypertensive drugs were given to 38.7% of patients with early neurological deterioration versus 16.9% in those without deterioration, P<0.05. In patients . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
G. Tsivgoulis, K. Spengos, K. N. Vemmos, J. Castillo, and A. Davalos
Blood Pressure in Acute Stroke and Its Prognostic Value * Response
Stroke, August 1, 2004; 35(8): 1786 - 1787.
[Full Text] [PDF]